about
A new strategy of promoting cisplatin chemotherapeutic efficiency by targeting endoplasmic reticulum stressInhibition of ERβ induces resistance to cisplatin by enhancing Rad51-mediated DNA repair in human medulloblastoma cell linesColorectal Carcinoma: A General Overview and Future Perspectives in Colorectal CancerProteasome inhibitor lactacystin enhances cisplatin cytotoxicity by increasing endoplasmic reticulum stress-associated apoptosis in HeLa cells.Mass spectrometry evidence for cisplatin as a protein cross-linking reagentRedefining the DNA-binding domain of human XPA.DNA repair: from genome maintenance to biomarker and therapeutic target.DMH1 (4-[6-(4-isopropoxyphenyl)pyrazolo[1,5-a]pyrimidin-3-yl]quinoline) inhibits chemotherapeutic drug-induced autophagy.Sensitization of Cervical Cancer Cells to Cisplatin by Genistein: The Role of NFκB and Akt/mTOR Signaling PathwaysHuman MLH1 status can potentially predict cisplatin sensitivity but not microsatellite instability in head and neck squamous cell carcinoma cells.Depletion of the cisplatin targeted HMGB-box factor UBF selectively induces p53-independent apoptotic death in transformed cells.Single-molecule kinetics reveal microscopic mechanism by which High-Mobility Group B proteins alter DNA flexibility.Calcium efflux from the endoplasmic reticulum regulates cisplatin-induced apoptosis in human cervical cancer HeLa cells.Cisplatin protects against acute liver failure by inhibiting nuclear HMGB1 releaseCisplatin-induced hair cell death requires STAT1 and is attenuated by epigallocatechin gallate.IGF-IR in neuroprotection and brain tumors.Cisplatin promotes mesenchymal-like characteristics in osteosarcoma through Snail.Can pharmacogenetics explain efficacy and safety of cisplatin pharmacotherapy?Volume-sensitive chloride channels are involved in cisplatin treatment of osteosarcoma.Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage.Cisplatin intrastrand adducts sensitize DNA to base damage by hydrated electronsNon-specificity and synergy at the binding site of the carboplatin-induced DNA adduct via molecular dynamics simulations of the MutSα-DNA recognition complex.Protein kinase C β inhibits autophagy and sensitizes cervical cancer Hela cells to cisplatin.Lysophosphatidic Acid Inhibits Apoptosis Induced by Cisplatin in Cervical Cancer Cells.Hydrated electrons react with high specificity with cisplatin bound to single-stranded DNA.Radiosensitization of DNA by Cisplatin Adducts Results from an Increase in the Rate Constant for the Reaction with Hydrated Electrons and Formation of Pt(I).Emerging molecular mechanisms in chemotherapy: Ca2+ signaling at the mitochondria-associated endoplasmic reticulum membranes.Genoprotective effects of gallic acid against cisplatin induced genotoxicity in bone marrow cells of miceCellular Pharmacology of Palladinum(III) Hematoporphyrin IX Complexes: Solution Stability, Antineoplastic and Apoptogenic Activity, DNA Binding, and Processing of DNA-Adducts
P2860
Q27014076-158A6CEA-BAC3-4878-92E2-94493302BD7EQ28481551-FE56AB76-E740-446B-A415-B6BE090AF338Q30238915-EE66E96D-BA81-45DF-828C-10035A6D83F3Q34540820-19EBAE1E-6AFB-4151-8454-D9670019B7EDQ35091564-82986583-4930-4212-9956-4EB79A51C275Q35211979-C0E3AA94-2AA6-4058-A223-2DE3FF53F96FQ35555880-064DF9A8-9AAC-415D-9373-95DACE117F86Q36238087-A223C457-DBBE-4A24-9ADB-AB858ABA22F0Q36296657-DD458349-8A14-4CE1-895F-E00EEAA9B80AQ36375191-16E1E9B5-4EE4-43B7-A3BE-E9CB3CFA11ABQ36413821-2D04C65C-A9C0-42CE-8A91-C9D17AA38C66Q36668931-49B80B4D-0F6D-4948-805C-299B990205ECQ36741804-FF964AB4-5025-417F-87F6-B35C06366CD8Q37007136-0E46BBD3-4168-406F-9955-681B1B34DF96Q37254857-A2BDF2A2-D51A-40AA-8EA1-C9E274E75CC4Q37409955-F4305EA1-15FF-4A0A-BA0D-E06AED13A165Q37582414-859A3379-F334-45F5-B240-53706ECDCB7FQ38276429-347FF991-1066-4B99-86DE-19BC9225C466Q38928791-6B0771DE-1968-4528-AC00-A4F00907FDD4Q41834934-7137AC47-CE4B-4575-8063-8FF8BEADEBF6Q41838079-87D79F68-E12D-49B9-AA7A-92E6220374F1Q41856985-4E032982-E6AC-438D-AA68-F3043E043995Q41946240-4E8D833D-A175-406F-A9EB-17D16CD51475Q41947077-21F4FA92-E653-4AB5-ADAC-B1A5DFDD6CDFQ43198861-AA789B71-51BD-4835-BA6A-B858510ABAA3Q43198865-416884E1-A32B-4E72-B81E-5E0BE321D389Q51737093-ACB0CB4E-175F-43DC-88A7-5713EF27516CQ57496938-CDE27461-0626-4C4A-834A-D12C8F7AD49BQ58766014-C3D75340-9D79-4D66-BD84-C706B9EB21AE
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Recognition and repair of DNA-cisplatin adducts.
@ast
Recognition and repair of DNA-cisplatin adducts.
@en
Recognition and repair of DNA-cisplatin adducts.
@nl
type
label
Recognition and repair of DNA-cisplatin adducts.
@ast
Recognition and repair of DNA-cisplatin adducts.
@en
Recognition and repair of DNA-cisplatin adducts.
@nl
prefLabel
Recognition and repair of DNA-cisplatin adducts.
@ast
Recognition and repair of DNA-cisplatin adducts.
@en
Recognition and repair of DNA-cisplatin adducts.
@nl
P1476
Recognition and repair of DNA-cisplatin adducts.
@en
P2093
Janusz Błasiak
Katarzyna Woźniak
P304
P577
2002-01-01T00:00:00Z